Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction | NEJM
Original Article from The New England Journal of Medicine — Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
Related Articles
Implantable cardioverter‐defibrillators in ischaemic versus non‐ischaemic heart failure: Insights from the VICTORIA trial
Mode of death stratified by implantable cardioverter-defibrillator (ICD) status. CI, confidence interval; CV, cardiovascular; HF, heart failure; HFrEF, heart failure with reduced ejection fraction; H…
Insights into the European heart failure epidemiology
Aims The Heart Failure Association (HFA) of the European Society of Cardiology (ESC), together with the National Heart Failure Societies (NHFS), designed the European Heart…
Integrated role of cardiac magnetic resonance and genetics in predicting left ventricular reverse remodelling in dilated and non‐dilated cardiomyopathy
An integrated approach including late gadolinium enhancement data and genetics to predict left ventricular reverse remodelling in patients with dilated and non-dilated left ventricular cardiomyopathy…
Integrated role of cardiac magnetic resonance and genetics in predicting left ventricular reverse remodelling in dilated and non‐dilated cardiomyopathy
An integrated approach including late gadolinium enhancement data and genetics to predict left ventricular reverse remodelling in patients with dilated and non-dilated left ventricular cardiomyopathy…
Ivabradine improves win ratios of heart failure outcomes in patients with reduced ejection fraction – insights from the SHIFT trial
Click on the article title to read more.
Mineralocorticoid Receptor Antagonists in End-Stage Renal Disease Under Renal Replacement Therapies: Bridging the Gap Between Cardiovascular and Systemic Benefit, From Heart Failure to Myocardial Infarction – PubMed
Mineralocorticoid Receptor Antagonists in End-Stage Renal Disease Under Renal Replacement Therapies: Bridging the Gap Between Cardiovascular and Systemic Benefit, From Heart Failure to Myocardial Infarction
Therapeutic decision making in tricuspid regurgitation: Many risk scores for transcatheter repair with no specific answer
Click on the article title to read more.
Mineralocorticoid receptor antagonists in end-stage renal… : Journal of Cardiovascular Pharmacology
An abstract is unavailable. This article is available as a PDF only.